| Monday | ||||
Asensus Surgical has… Asensus Surgical has received CE Mark for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit. With this CE Marking, the expanded ISU capabilities are now commercially available across all of the company's key geographies, including the EU, Japan, and the U.S. In addition, this approval included a review of the Senhance Surgical System platform. The Senhance Surgical System is powered by the Intelligent Surgical Unit. | ||||
| Over a week ago | ||||
Asensus Surgical… Asensus Surgical announced that Kitakyushu General Hospital, a hospital in the Kyushu area of Japan, entered into an agreement to lease and utilize a second Senhance Surgical System, at the end of December 2022. Kitakyushu is the first hospital to install multiple Senhance Surgical Systems. The hospital previously initiated their first Senhance system in January of 2020, and since has completed over 300 procedures utilizing Performance-Guided Surgery. | ||||
| Over a month ago | ||||
Asensus Surgical… Asensus Surgical announced that Kashiwa Kosei General Hospital in Kashiwa, Japan has entered into an agreement to lease and utilize a Senhance Surgical System. | ||||
Asensus Surgical… Asensus Surgical announced that GPR Gesundheits- und Pflegezentrum Klinikum of Russelsheim, Germany has entered into an agreement to lease and utilize a Senhance Surgical System. | ||||
Asensus Surgical… Asensus Surgical announced that a Senhance Surgical System has been sold to the company's distribution partner in Germany focused on Eastern Europe and the Commonwealth of Independent States region. The Senhance System will be placed at an end user oncology focused hospital. | ||||
| Over a quarter ago | ||||
Asensus Surgical… Asensus Surgical announced the Clinic for General and Visceral Surgery at the St. Bernhard Hospital in Kamp-Lintfort, Germany has entered into an agreement to lease and utilize a Senhance Surgical System. Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence through machine learning, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization. | ||||
Asensus Surgical… Asensus Surgical announced Saiseikai Shiga Hospital in Ritto, Japan has entered into an agreement to lease and utilize a Senhance Surgical System. | ||||
Cantor Fitzgerald analyst… Cantor Fitzgerald analyst Ross Osborn initiated coverage of Asensus Surgical with an Overweight rating and $1.50 price target. Asensus is a "fast-growing," robotic-assisted Surgery company that is digitizing the interface between the surgeon and patient to enable performance-guidance surgery through machine vision, augmented intelligence, and deep learning capabilities, Osborn tells investors in a research note. The analyst believes the company's Senhance system should drive better and more-consistent procedural outcomes. Osborn holds a favorable view of the estimated $56B laparoscopic surgery market and believes Asensus shares are "attractively valued." | ||||
Cantor Fitzgerald analyst… Cantor Fitzgerald analyst Ross Osborn initiated coverage of Asensus Surgical with an Overweight rating and $1.50 price target. | ||||
H.C. Wainwright analyst… H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm's price target on Asensus Surgical to $3 from $4 and keeps a Buy rating on the shares post the Q2 results. | ||||
